Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy

BACKGROUND: In cervical cancer patients with intermediate-risk factors, the optimal adjuvant therapy is still controversial. We undertook a randomized trial (ClinicalTrials.gov Identifier: NCT01418859) to compare the efficacy and toxicity of concurrent chemoradiotherapy with topotecan and cisplatin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Sun, Wenze, Wang, Tao, Shi, Fan, Wang, Jiquan, Wang, Juan, Hui, Beina, Zhang, Yingbing, Lu, Jinli, Chen, Hongwei, Liu, Zi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4425857/
https://ncbi.nlm.nih.gov/pubmed/25935645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1355-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki